Orna Therapeutics Revenue and Competitors

Boston, MA USA

Location

$100M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Orna Therapeutics's estimated annual revenue is currently $29.1M per year.(i)
  • Orna Therapeutics's estimated revenue per employee is $193,750
  • Orna Therapeutics's total funding is $100M.

Employee Data

  • Orna Therapeutics has 150 Employees.(i)
  • Orna Therapeutics grew their employee count by -1% last year.

Orna Therapeutics's People

NameTitleEmail/Phone
1
Founder, Director Business Development, Former Board DirectorReveal Email/Phone
2
CEOReveal Email/Phone
3
Interim VP, Business DevelopmentReveal Email/Phone
4
Chief Scientific OfficerReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Head Facilities & OperationsReveal Email/Phone
7
Head People and CultureReveal Email/Phone
8
VP Regulatory AffairsReveal Email/Phone
9
Head Information TechnologyReveal Email/Phone
10
VP, Portfolio & Program ManagementReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Orna Therapeutics?

Orna Therapeutics is a venture-backed, Cambridge-based startup creating a pipeline of circular RNA (oRNA) therapeutics based on technology originated at MIT. Our mission is to address diseases not accessible through existing technologies, bringing meaningful therapies to patients in need.

keywords:N/A

$100M

Total Funding

150

Number of Employees

$29.1M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Orna Therapeutics News

2022-03-30 - China joins race to build a better Covid-19 vaccine with circRNA tech

US start-up Orna Therapeutics is looking at ways to use circular RNA technology to develop therapeutics for cancer, autoimmune diseases,...

2022-03-22 - Orna Therapeutics Bolsters Leadership Team with Key ...

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA™)...

2021-02-24 - Orna Therapeutics : Launches with over $100M Raised to Develop a New Class of Fully Engineered Circular RNA Therapies

CAMBRIDGE, Mass., Feb. 24, 2021 /PRNewswire/ -- Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNAs), today announced the completion of its $80 million Series A financing. Founded on groundbreaking rese ...

2021-02-24 - Orna Therapeutics, Inc. announced that it has received $80 million in funding from a group of investors

Orna Therapeutics announced that it has received $80 million in series A round of funding co-led by returning investor MPM Capital, Taiho Ventures, LLC and F2 Capital Ltd on February 24, 2021. The transaction included participation from leading strategic investors Astellas Venture Management LLC ...

2021-02-24 - Orna Therapeutics Raises $100M

Orna Therapeutics, a Cambridge, Mass.-based biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNAs), completed an $80m Series A financing. The round was co-led by MPM Capital, Taiho Ventures, and F2 Ventures, with participati ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M1507%N/A
#2
$40.4M1507%N/A
#3
$29.1M150-3%$53.8M
#4
$24.9M151-1%N/A
#5
$37.7M151N/AN/A